Cargando…

Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS

Detalles Bibliográficos
Autores principales: Scheibe, Franziska, Metz, Imke, Radbruch, Helena, Siebert, Eberhard, Wolf, Stefan, Köhnlein, Martin, Harms, Lutz, Meisel, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047475/
https://www.ncbi.nlm.nih.gov/pubmed/30027105
http://dx.doi.org/10.1212/NXI.0000000000000479
_version_ 1783339950521974784
author Scheibe, Franziska
Metz, Imke
Radbruch, Helena
Siebert, Eberhard
Wolf, Stefan
Köhnlein, Martin
Harms, Lutz
Meisel, Andreas
author_facet Scheibe, Franziska
Metz, Imke
Radbruch, Helena
Siebert, Eberhard
Wolf, Stefan
Köhnlein, Martin
Harms, Lutz
Meisel, Andreas
author_sort Scheibe, Franziska
collection PubMed
description
format Online
Article
Text
id pubmed-6047475
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-60474752018-07-19 Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS Scheibe, Franziska Metz, Imke Radbruch, Helena Siebert, Eberhard Wolf, Stefan Köhnlein, Martin Harms, Lutz Meisel, Andreas Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2018-07-10 /pmc/articles/PMC6047475/ /pubmed/30027105 http://dx.doi.org/10.1212/NXI.0000000000000479 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Clinical/Scientific Notes
Scheibe, Franziska
Metz, Imke
Radbruch, Helena
Siebert, Eberhard
Wolf, Stefan
Köhnlein, Martin
Harms, Lutz
Meisel, Andreas
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
title Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
title_full Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
title_fullStr Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
title_full_unstemmed Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
title_short Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
title_sort drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in ms
topic Clinical/Scientific Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047475/
https://www.ncbi.nlm.nih.gov/pubmed/30027105
http://dx.doi.org/10.1212/NXI.0000000000000479
work_keys_str_mv AT scheibefranziska drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms
AT metzimke drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms
AT radbruchhelena drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms
AT sieberteberhard drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms
AT wolfstefan drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms
AT kohnleinmartin drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms
AT harmslutz drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms
AT meiselandreas drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms